identification
115 results
1 - 100
ibritumomab- activated charcoal
- Medication Errors: Improving Practices and Patient Safety
- anticonvulsants
- antiarrhythmics
- corticosteroids
- vasopressin
- factor ix (human)
- procainamide
- moricizine
- pyridostigmine
- anticoagulants
- penicillin G aqueous
- flecainide
- mexiletine
- aminoglutethimide
- propafenone
- lecanemab
- dasiglucagon
- antihemophilic factor
- digitoxin
- miglitol
- propylthiouracil
- QUINIDINE
- tocainide
- acebutolol
- antidiabetics
- glucagon
- phytonadione
- repaglinide
- troglitazone
- penicillin V
- acarbose
- tiaGABine
- insulin glargine
- carvedilol
- cortisone
- insulin zinc suspension (lente insulin)
- insulin detemir
- isatuximab
- moclobemide
- methIMAzole
- nateglinide
- insulin zinc suspension, extended (ultralente insulin)
- betamethasone (systemic)
- SITagliptin
- insulin (rDNA origin) inhalation powder
- insulin, human inhalation
- cenobamate
- gliclazide
- acetoHEXAMIDE
- atenolol
- rosiglitazone
- insulin lispro
- NPH insulin (isophane insulin suspension)
- insulin regular
- insulin degludec
- betaxolol
- bisoprolol
- chlorproPAMIDE
- dantrolene
- felbamate
- OXcarbazepine
- penbutolol
- pioglitazone
- TOLAZamide
- warfarin
- insulin aspart
- INSULIN (mixtures)
- glimepiride
- nebivolol
- upadacitinib
- carteolol
- desmopressin
- ethosuximide
- metoprolol
- primidone
- TOLBUTamide
- glyBURIDE
- pregabalin
- isocarboxazid
- phenelzine
- eslicarbazepine
- colesevelam
- diazePAM
- mitotane
- insulin glulisine
- glipiZIDE
- buprenorphine/naloxone
- Overview of Risk Evaluation and Mitigation Systems (REMS)
- insulin glargine/lixisenatide
- digoxin
- metFORMIN
- nadolol
- tranylcypromine
- liraglutide
- albiglutide
- dulaglutide
- clorazepate